Puma Biotechnology amends bylaws to align with Delaware law updates

PUMA BIOTECHNOLOGY, INC.

Board adopted Fifth Amended and Restated Bylaws on June 19, 2025.
Changes primarily reflect updates to Delaware General Corporation Law.
Includes conforming, ministerial, and other related revisions.
No substantive operational or financial changes disclosed.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PUMA BIOTECHNOLOGY, INC.: Amended and restated bylaws primarily to align with updates to Delaware law, with conforming changes (effective 2025-06-19).

Change: bylaw amendment
Effective: 2025-06-19

Exact text from the filing

On June 19, 2025, the Board of Directors of Puma Biotechnology, Inc. (the “Company”) approved and adopted an amendment and restatement of the Company’s Fourth Amended and Restated Bylaws (as so amended, the “Amended Bylaws”) primarily to revise provisions in order to be more in line with certain updates to Delaware law.

View on SEC.gov

Browse all governance changes →

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-021153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.